Apotea (ST:APOTEA) — Stock Price
Apotea (ST:APOTEA) is currently trading at Skr72.75 SEK, down 1.42% today. Over the past 52 weeks, shares have ranged between Skr55.58 and Skr114.68. This page tracks Apotea's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see APOTEA market cap.
Apotea (APOTEA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Apotea's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
Apotea Income Statement — Revenue, Profit & Earnings by Year
Apotea's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | Skr7.20 Billion | Skr6.54 Billion | Skr5.45 Billion | Skr4.88 Billion |
| Cost of Revenue | Skr5.27 Billion | Skr4.75 Billion | Skr4.00 Billion | Skr3.61 Billion |
| Gross Profit | Skr1.94 Billion | Skr1.79 Billion | Skr1.45 Billion | Skr1.27 Billion |
| Research & Development | — | — | — | — |
| SG&A | — | — | — | — |
| Total Operating Expenses | Skr6.90 Billion | Skr6.28 Billion | Skr5.34 Billion | Skr4.83 Billion |
| Operating Income | Skr303.70 Million | Skr262.80 Million | Skr112.70 Million | Skr49.00 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | Skr12.00 Million | Skr5.30 Million | Skr4.60 Million | Skr3.80 Million |
| Income Before Tax | Skr289.80 Million | Skr264.70 Million | Skr108.70 Million | Skr31.00 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | Skr228.70 Million | Skr214.90 Million | Skr87.00 Million | Skr19.90 Million |
Apotea Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Apotea's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | Skr1.98 Billion | Skr1.63 Billion | Skr1.34 Billion | Skr1.25 Billion |
| Total Current Assets | Skr1.12 Billion | Skr1.02 Billion | Skr781.50 Million | Skr721.30 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | Skr355.40 Million | Skr358.80 Million | Skr289.40 Million | Skr246.00 Million |
| Inventory | Skr651.90 Million | Skr562.30 Million | Skr410.10 Million | Skr390.00 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | Skr30.50 Million | Skr32.00 Million | Skr32.50 Million | Skr57.50 Million |
| Total Liabilities | Skr1.12 Billion | Skr991.70 Million | Skr911.30 Million | Skr897.50 Million |
| Total Current Liabilities | Skr871.50 Million | Skr880.80 Million | Skr756.70 Million | Skr716.40 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | — | Skr52.30 Million | Skr47.80 Million | Skr93.60 Million |
| Total Stockholder Equity | Skr844.00 Million | Skr615.20 Million | Skr403.70 Million | Skr327.50 Million |
| Retained Earnings | Skr832.60 Million | Skr602.20 Million | Skr388.70 Million | Skr312.30 Million |
Apotea Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Apotea generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | Skr333.30 Million | Skr206.20 Million | Skr215.80 Million | Skr31.50 Million |
| Capital Expenditures | Skr215.60 Million | Skr163.80 Million | Skr121.10 Million | Skr142.10 Million |
| Free Cash Flow | Skr117.70 Million | Skr42.40 Million | Skr94.70 Million | Skr-110.60 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | — | — | — | Skr28.50 Million |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | Skr162.30 Million | Skr129.60 Million | Skr112.70 Million | Skr70.00 Million |
| Change in Cash | Skr3.50 Million | Skr8.30 Million | Skr900.00K | Skr-63.60 Million |
Apotea Earnings History — EPS Actual vs. Analyst Estimates
Track Apotea's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 17, 2026 | — | 0.75 | — |
| Apr 29, 2026 | 0.76 | 0.55 | +38.18% |
| Feb 04, 2026 | 0.15 | 0.37 | -59.46% |
| Nov 06, 2025 | 0.67 | 0.58 | +15.52% |
| Jul 18, 2025 | 0.69 | — | — |
| May 08, 2025 | 0.69 | 0.53 | +30.19% |
| Feb 06, 2025 | 0.47 | — | — |